Furthermore, the regrowth model could be reproduced with commercially available cell lines, including LGR5-positive cells, and similar observations were made in in vitro and in vivo drug screening systems as with PLR123, indicating that the analysis of the regrowth process in highly stem-like colorectal cancer is useful. This evidence concerns the gene LGR5 and colorectal cancer.